Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,234.00    -22.00 (-1.75%)
Bid:
1,234.00
Ask:
1,238.00
Spread: 4.00 (0.324%)
Market Cap: £565.49m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract Win

13 Aug 2015 07:00

RNS Number : 9010V
Cohort PLC
13 August 2015
Β 

ο»Ώ

13 August 2015

Cohort plc

("Cohort" or "the Group")

Β 

Cohort's MCL subsidiary wins MOD hearing protection contract

Β 

Cohort, the independent technology group, is pleased to announce that its subsidiary Marlborough Communications Ltd. (MCL) has been awarded a contract by the UK Ministry of Defence to provide the armed forces with tactical hearing protection systems for the dismounted close combat userΒ ("THPS DCCU"). The award follows a competitive tender process.

Β 

The initial order value is Β£11.2m. Further orders are expected over the duration of the contract and the delivery schedule and total contract value are still the subject of discussion with the customer. The contract has been awarded for four years, with an option to extend it for a further three years.

Β 

The solution being supplied by MCL was developed in partnership with INVISIO Communications, a leading Danish audio technology company.

Β 

This contract win follows on from MCL's previous UK MOD win earlier in the year, supplying its Tactical In-Ear Protection Plugs as part of the tactical hearing protection system for the basic user soldier.

Β 

Andrew Thomis, Chief Executive of Cohort plc, said:

"We are delighted that MCL has been awarded the THPS DCCU contract. We look forward to working with the UK MOD to deliver this important equipment to soldiers.

"The contract will add significantly to our already strong order book, which substantially underpins our revenues for Cohort's current financial year."

Β 

ENDS

Β 

Β 

For further information please contact:

Cohort plc

Andy Thomis, Chief Executive

Simon Walther, Finance Director

Β 

0118 909 0390

Investec Bank plc

Keith Anderson / Daniel Adams

020 7597 5970

MHP Communications Limited

Reg Hoare / Jamie Ricketts

020 3128 8100

Β 

NOTES TO EDITORS

Β 

Cohort plc (www.cohortplc.com) is the parent company for four innovative, agile and responsive businesses working primarily for defence, wider government and industry clients.

Β 

Β· SCS (www.scs-ltd.co.uk) - a defence consultancy, combining technical expertise with armed forces experience and domain knowledge. Owned by Cohort since flotation in March 2006.

Β· MASS (www.mass.co.uk) - a specialist defence and technology business, focused mainly on electronic warfare, information systems and cyber security. Acquired by Cohort in August 2006.

Β· SEA (www.sea.co.uk) - an advanced electronic systems and software house operating in the defence, transport and offshore energy markets. Acquired by Cohort in October 2007.

Β 

Β· MCL (www.marlboroughcomms.com) - an expert in sourcing, design and integration of communications and surveillance technology, as well as support and training for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014.

Β 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 650 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Devon, Lincolnshire, Somerset, Surrey and Scotland.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
CNTPKBDKABKDQFD
Date   Source Headline
27th Jun 20197:00 amRNSNotice of Results (change of date)
13th Jun 20195:06 pmRNSHolding(s) in Company
24th May 20197:00 amRNSNotice of Final Results
16th May 20193:22 pmRNSEBT Purchase
2nd May 20197:00 amRNSContract Announcement
25th Apr 20191:29 pmRNSDirector/PDMR Shareholding
16th Apr 201910:35 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSContract Announcement
13th Mar 201911:52 amRNSDirector/PDMR Shareholding
1st Mar 201910:31 amRNSDirector/PDMR Shareholding
14th Feb 20197:00 amRNSContract announcement
12th Feb 20193:49 pmRNSDirector/PDMR Shareholding
12th Feb 20199:15 amRNSContract Announcement
18th Jan 201911:58 amRNSDirector/PDMR Shareholding
9th Jan 20199:41 amRNSDirector/PDMR Shareholding
4th Jan 20197:00 amRNSInterim Report 2018
24th Dec 20187:00 amRNSContract Announcement
20th Dec 20182:40 pmEQSEdison Investment Research Limited: Edison issues outlook on Cohort (CHRT)
12th Dec 20187:00 amRNSHalf-year Report
12th Dec 20187:00 amRNSCohort acquires Chess Technologies
26th Nov 20187:00 amRNSContract Announcement
20th Nov 20187:00 amRNSContract Announcement
19th Nov 20184:26 pmRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSContract Announcement
13th Nov 20187:00 amRNSContract Announcement
31st Oct 20189:38 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSContract Announcement
15th Oct 20182:00 pmRNSDirector/PDMR Shareholding
8th Oct 20187:00 amRNSContract Announcement
5th Oct 20181:57 pmRNSChange of Registered Office
4th Oct 20187:00 amRNSContract Announcement
21st Sep 20184:25 pmRNSHolding(s) in Company
20th Sep 20183:52 pmRNSDirector Shareholdings
13th Sep 20182:59 pmRNSHolding(s) in Company
12th Sep 20183:21 pmRNSResult of AGM
11th Sep 201811:20 amRNSAGM Statement
6th Sep 20183:20 pmRNSHolding(s) in Company
5th Sep 201810:27 amRNSDirector Share Options
30th Aug 201811:31 amRNSAnnual Report
28th Aug 20183:09 pmRNSHolding(s) in Company
14th Aug 20189:15 amRNSDirector/PDMR Shareholding
31st Jul 20182:16 pmRNSHolding(s) in Company
6th Jul 20184:34 pmRNSDirector/PDMR Shareholding
3rd Jul 20187:00 amRNSFinal Results
29th May 20185:29 pmRNSEBT Purchase
21st May 201811:32 amRNSNotice of Results
19th Apr 20184:53 pmRNSDirector Shareholding
14th Mar 20188:53 amRNSDirector Shareholdings
16th Feb 20181:28 pmRNSDirector/PDMR Shareholding
12th Feb 201811:30 amRNSEBT Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.